健康之路
健康之路
건강지로
HEALTH
2015年
1期
27-27
,共1页
托拉塞米%充血性心力衰竭%疗效及安全性
託拉塞米%充血性心力衰竭%療效及安全性
탁랍새미%충혈성심력쇠갈%료효급안전성
Torasemide%Chronic congestive heart failure%Ef ect and safet
目的：：观察托拉塞米治疗慢性充血性心力衰竭患者的临床疗效及安全性。方法：选取98例慢性充血性心力衰竭患者,将其随机分为托拉塞米组与呋塞米组,在心力衰竭常规治疗方法一致的情况下,分别予托拉塞米与呋塞米20mg静推。治疗10d后,记录两组患者治疗前后血压、血钾浓度、BNP值及 EF值。结果：两组患者血压均有下降。但组间差异无统计学意义；托拉塞米组低血钾发生率更低,BNP下降且心功能改善更明显。结论：托拉塞米可显著改善慢性充血性心力衰竭患者的心功能,降低血浆BNP水平,低血钾及血压变化等不良反应较轻。
目的：：觀察託拉塞米治療慢性充血性心力衰竭患者的臨床療效及安全性。方法：選取98例慢性充血性心力衰竭患者,將其隨機分為託拉塞米組與呋塞米組,在心力衰竭常規治療方法一緻的情況下,分彆予託拉塞米與呋塞米20mg靜推。治療10d後,記錄兩組患者治療前後血壓、血鉀濃度、BNP值及 EF值。結果：兩組患者血壓均有下降。但組間差異無統計學意義；託拉塞米組低血鉀髮生率更低,BNP下降且心功能改善更明顯。結論：託拉塞米可顯著改善慢性充血性心力衰竭患者的心功能,降低血漿BNP水平,低血鉀及血壓變化等不良反應較輕。
목적：：관찰탁랍새미치료만성충혈성심력쇠갈환자적림상료효급안전성。방법：선취98례만성충혈성심력쇠갈환자,장기수궤분위탁랍새미조여부새미조,재심력쇠갈상규치료방법일치적정황하,분별여탁랍새미여부새미20mg정추。치료10d후,기록량조환자치료전후혈압、혈갑농도、BNP치급 EF치。결과：량조환자혈압균유하강。단조간차이무통계학의의；탁랍새미조저혈갑발생솔경저,BNP하강차심공능개선경명현。결론：탁랍새미가현저개선만성충혈성심력쇠갈환자적심공능,강저혈장BNP수평,저혈갑급혈압변화등불량반응교경。
Objective:To observe the curative ef ect and safety of torasemide used to cure chronic congestive heart failur.Methods:98 patients with chronic CHF were randomly divided in two groups,the torasemide group and the furosemide group.In the case of The same conventional treatment of CHF.Al the patients were given torasemide or furosemide 20 mg intravenous injection.10 days after the treatment,Recorded the blood pressure,serum potassium,BNP and EF.Result:Both groups had decreased blood pressure,however,no signifcant dif erence between groups.Torasemide group had a lower inG cidence of hypokalemia and more significant improvement of cardiac function.Conclusion:Torasemide can improve the heatr function and reduce the plasma level of BNP in patients with chronic CHF and have a lower incidence of hypokalemia.
